MedTrace Logo

Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia

NCT07429591 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-02-24

No results posted yet for this study

Summary

The goal of this clinical trial is to test a risk assessment screening and intervention for caregivers of people with dementia. The main questions it aims to answer are:

1. What are the harms and benefits of administering the elder abuse risk assessment screening?
2. What are the harms and benefits of administering the caregiver intervention?

Researchers will compare participants who receive the screening and caregiver intervention to a group who does not receive the caregiver intervention and a group who receives neither the screening or the caregiver intervention to answer these questions.

Participants will:

* Complete two surveys, three months apart
* Complete a 5-item screening tool, if assigned to one of the screening groups
* Complete a 3-session caregiver intervention, if assigned to that group

Conditions

  • Caregivers of Alzheimer's Disease or Memory Problem Patients
  • Caregiver Wellbeing
  • Elder Abuse

Interventions

BEHAVIORAL

Risk Assessment Screening

A five question tool that can be delivered verbally or through written self-administration.

BEHAVIORAL

Coach and Website Intervention

A three-session community health worker intervention, including a caregiver information website.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Bonnie Olsen, PhD · University of Southern California

  • Laura Mosqueda, MD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2027-06-01
Completion
2027-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07429591 on ClinicalTrials.gov